We hypothesised that RYGB-D FMT leads to increased insulin sensitivity, in conjunction with faster intestinal transit time, as this would provide less opportunity for the bacterial translocation associated with inflammation and insulin resistance. The gene discussed is INS; the disease is Insulin resistance.